Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 12.06B |
| Enterprise Value | 10.05B |
| P/E Ratio | 17.57 |
| PEG Ratio | 1.68 |
| Price/Sales Ratio | 2.65 |
| Price/Book Ratio | 2.27 |
| Enterprise/Revenue | 2.42 |
| Enterprise/EBITDA | 11.72 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.15 |
| Operating Margin | 0.18 |
AD
Management Effectiveness
| Return On Assets | 0.1 |
| Return On Equity | 0.14 |
Income Statement
| Revenue | 3.87B |
| Revenue/Share | 9.01 |
| Gross Profit | 1.9B |
| EBITDA | 810.78M |
| Net Income | 581.49M |
| Diluted EPS | 1.35 |
Balance Sheet
| Total Cash | 2.56B |
| Total Cash/Share | 5.9 |
| Total Debt | 85.35M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 5.06 |
| Book Value Per Share | 10.91 |
Price History
| 52-Week Change | -13.23 |
| 52-Week High | 30.18 |
| 52-Week Low | 21.22 |
| Moving Average 50 Days | 23.91 |
| Moving Average 200 Days | 26.48 |
Statistics
| Average Volume | 4.65M |
| Shares Outstanding | 431.05M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.62 |
| Trailing Annual Dividend Yield | 2.58 |
| Payout Ratio | 0 |
| Last Split Factor | 13:10 |
| Last Split Date | July 21, 2015 |
AD
